EUVIMEDEUVIMED entdecken
Übersichtsarbeit

HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases

Richa Singh, Aaina Singh Rathore, Hagera Dilnashin, Priyanka Kumari Keshri, Nitesh Kumar Gupta, Singh Ankit Satya Prakash, Walia Zahra, Shekhar Singh, Surya Pratap Singh

Molecular Neurobiology · 2024-11 · 61 (11) · 9110-9124

DOI: 10.1007/s12035-024-04115-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 08.04.2024. Verfasst von Richa Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005 (U.P.), India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Histone Deacetylases, Histone Acetyltransferases, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 158 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In view of the increasing risk of neurodegenerative diseases, epigenetics plays a fundamental role in the field of neuroscience. Several modifications have been studied including DNA methylation, histone acetylation, histone phosphorylation, etc. Histone acetylation and deacetylation regulate gene expression, and the regular activity of histone acetyltransferases (HATs) and histone deacetylases (HDACs) provides regulatory stages for gene expression and cell cycle. Imbalanced homeostasis in these enzymes causes a detrimental effect on neurophysiological function. Intriguingly, epigenetic remodelling via histone acetylation in certain brain areas has been found to play a key role in the neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. It has been demonstrated that a number of HATs have a role in crucial brain processes such regulating neuronal plasticity and memory formation. The most recent therapeutic methods involve the use of small molecules known as histone deacetylase (HDAC) inhibitors that antagonize HDAC activity thereby increase acetylation levels in order to prevent the loss of HAT function in neurodegenerative disorders. The target specificity of the HDAC inhibitors now in use raises concerns about their applicability, despite the fact that this strategy has demonstrated promising therapeutic outcomes. The aim of this review is to summarize the cross-linking between histone modification and its regulation in the pathogenesis of neurological disorders. Furthermore, these findings also support the notion of new pharmacotherapies that target particular areas of the brain using histone deacetylase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesHistone DeacetylasesHistone AcetyltransferasesHistone Deacetylase InhibitorsHumansAnimalsHistonesAcetylationEpigenesis, Genetic

Stichwörter der Autor:innen

Alzheimer’s diseaseEpigeneticsHistone acetyltransferaseHistone decetyltransferaseHuntington’s diseaseNeurodegenerationParkinson’s diseasec-AMP response binding element

Substanzen

Histone DeacetylasesHistone AcetyltransferasesHistone Deacetylase InhibitorsHistones

Autor:innen und Institutionen

  • Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005 (U.P.), India.
  • Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005 (U.P.), India. sps.biochem23@gmail.com.

Zitieren

APA

Singh, R., Rathore, A. S., Dilnashin, H., Keshri, P. K., Gupta, N. K., Prakash, S. A. S., Zahra, W., Singh, S., & Singh, S. P. (2024). HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases. Molecular Neurobiology, 61(11), 9110-9124. https://doi.org/10.1007/s12035-024-04115-6

Vancouver

Singh R, Rathore AS, Dilnashin H, Keshri PK, Gupta NK, Prakash SAS, et al. HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases. Molecular Neurobiology. 2024;61(11):9110-9124. doi:10.1007/s12035-024-04115-6

BibTeX
@article{Singh2024,
  author = {Singh, Richa and Rathore, Aaina Singh and Dilnashin, Hagera and Keshri, Priyanka Kumari and Gupta, Nitesh Kumar and Prakash, Singh Ankit Satya and Zahra, Walia and Singh, Shekhar and Singh, Surya Pratap},
  title = {HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases},
  journal = {Molecular Neurobiology},
  year = {2024},
  volume = {61},
  number = {11},
  pages = {9110--9124},
  doi = {10.1007/s12035-024-04115-6}
}
Kostenlos starten →